| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/22/2001 | WO2001013031A2 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 02/22/2001 | WO2001012856A2 Analysis of sequence tags with hairpin primers |
| 02/22/2001 | WO2001012855A2 Binary encoded sequence tags |
| 02/22/2001 | WO2001012836A1 Crystal of a truncated protein construct containing a coagulation factor viii c2 domain in the presence or absence of a bound ligand and methods of use thereof |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012818A1 Neutral cerebral-sphingomyelinase |
| 02/22/2001 | WO2001012816A2 Porcine endovirus gag and env and diagnostic uses thereof |
| 02/22/2001 | WO2001012812A2 Baff receptor (bcma), an immunoregulatory agent |
| 02/22/2001 | WO2001012811A1 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/22/2001 | WO2001012810A1 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 02/22/2001 | WO2001012807A1 MODIFIED cDNA OF RAT bcl-x GENE AND MODIFIED PROTEIN |
| 02/22/2001 | WO2001012806A2 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 02/22/2001 | WO2001012805A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 02/22/2001 | WO2001012803A2 Methods and compositions for restoring antibiotic susceptibility in glycopeptide-resistant enterococcus |
| 02/22/2001 | WO2001012795A1 COMPOSITION AND METHOD FOR TREATING DISEASE BY INCREASING ACTIVATED α2 MACROGLOBULIN IN THE BLOOD AND EXTRAVASCULAR TISSUE |
| 02/22/2001 | WO2001012793A1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012789A2 APOLIPOPROTEIN B mRNA-SPECIFIC RIBOZYME |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012784A1 METHOD FOR TREATMENT OF β-HEMOGLOBINOPATHIES |
| 02/22/2001 | WO2001012781A1 13 human colon and colon cancer associated proteins |
| 02/22/2001 | WO2001012777A2 Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species |
| 02/22/2001 | WO2001012776A2 18 human secreted proteins |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012718A1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012672A2 Cytokine receptor common gamma chain like |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012669A1 Vegf-d and angiogenic use thereof |
| 02/22/2001 | WO2001012668A1 Cathelicidin-derived peptides with broad spectrum antimicrobial activity |
| 02/22/2001 | WO2001012666A1 Parvovirus ns1 variants |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012663A2 Hematopoietic regulatory factors and methods of use thereof |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012661A2 RECEPTOR-MEDIATED UPTAKE OF AN EXTRACELLULAR BCL-xL FUSION PROTEIN INHIBITS APOPTOSIS |
| 02/22/2001 | WO2001012658A2 Human icos ligand and application thereof |
| 02/22/2001 | WO2001012656A1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 02/22/2001 | WO2001012655A1 Peptides consisting of fragments of gli-1 and sufuh and their use |
| 02/22/2001 | WO2001012654A2 Orally active peptides that prevent cell damage and death |
| 02/22/2001 | WO2001012651A2 Use of colostrinin, constituent peptides thereof, and analogs thereof to promote neural cell differentiation |
| 02/22/2001 | WO2001012650A2 Use of colostrinin, constituent peptides thereof, and analogs thereof as oxidative stress regulators |
| 02/22/2001 | WO2001012648A1 Novel transcription factor, bp1 |
| 02/22/2001 | WO2001012622A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012593A1 Arylsulfonanilide derivatives |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012236A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 02/22/2001 | WO2001012234A1 Gene transfer imaging and uses thereof |
| 02/22/2001 | WO2001012233A2 Sustained release formulation of a peptide |
| 02/22/2001 | WO2001012232A2 Process to make a sustained release formulation |
| 02/22/2001 | WO2001012230A1 The nasal transmucosal delivery of peptides conjugated with biocompatible polymers |
| 02/22/2001 | WO2001012229A1 Pharmaceutical compositions for oral and topical administration |
| 02/22/2001 | WO2001012222A1 Immunological tolerance-induction agent |
| 02/22/2001 | WO2001012217A1 Therapeutic antibody against muc-1 antigen and methods for their use |
| 02/22/2001 | WO2001012214A2 MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) |
| 02/22/2001 | WO2001012213A2 Ttp-related zinc finger domains and methods of use |
| 02/22/2001 | WO2001012212A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | WO2001012210A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase raf and ras |
| 02/22/2001 | WO2001012190A1 Partial agonists at the glycine modulatory site of the nmda receptor for treating cognitive dysfunction |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |
| 02/22/2001 | WO2001012184A1 Neurotherapeutic composition and method |
| 02/22/2001 | WO2001012182A1 Use of proteinase inhibitor in order to inhibit the cleavage of growth factor precursor |
| 02/22/2001 | WO2001012172A1 Treatment of metastatic disease |
| 02/22/2001 | WO2001012171A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of behavioral diseases |
| 02/22/2001 | WO2001012168A2 Antiviral pharmaceutical compositions containing iron chelators |
| 02/22/2001 | WO2001012164A1 Oral form of administration containing probiotic micro-organisms |
| 02/22/2001 | WO2001012160A1 Microparticles for pulmonary administration |
| 02/22/2001 | WO2001012155A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | WO2001012133A2 Cosmetic compositions with self-warming component |
| 02/22/2001 | WO2001012127A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 02/22/2001 | WO2001012126A2 Cardiomyocyte regeneration |
| 02/22/2001 | WO2001012112A2 Prevention of posterior capsular opacification |
| 02/22/2001 | WO2001011952A1 Transgenic prothrombin and related thrombin precursors and transgenics, methods, compositions, uses and the like relating thereto |
| 02/22/2001 | WO2001011949A1 Cd39/ecto-adpase for treatment of thrombotic and ischemic disorders |
| 02/22/2001 | WO2001011937A2 Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000078788B1 NOVEL cDNA ASSOCIATED WITH RENAL DISEASE |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000075281A9 Supercritical fluid-assisted nebulization and bubble drying |
| 02/22/2001 | WO2000073427A3 Acetylcholinesterase-derived peptides and uses thereof |
| 02/22/2001 | WO2000073330A3 Method and compositions relating to insulin resistance disorders |
| 02/22/2001 | WO2000073329A3 Uses of notch related genes |
| 02/22/2001 | WO2000072863A3 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 02/22/2001 | WO2000072742A3 Methods and materials for generating sh3 domains with tailored binding properties |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000064936A3 PEPTIDE HOMODIMERS AND PEPTIDE HETERODIMERS, DERIVED FROM INTERFERON α2 |
| 02/22/2001 | WO2000061761A3 Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| 02/22/2001 | WO2000058483A3 Protozoan expression system |
| 02/22/2001 | WO2000055633A3 Methods of screening for colorectal cancer modulators |
| 02/22/2001 | WO2000055314A3 Inhibitors of endothelin-1 synthesis |
| 02/22/2001 | WO2000040614A3 Characterization of the soc/crac calcium channel protein family |
| 02/22/2001 | WO2000036107A3 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 02/22/2001 | WO2000023100A8 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 02/22/2001 | WO2000021549A8 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | WO1999058680A3 Method for diagnosis and treatment of haemophilia a patients with an inhibitor |
| 02/22/2001 | WO1999049883A3 Oxidized thymosin beta 4 |
| 02/22/2001 | DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination |